List of insiders holdings for NOVAVAX INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Cadila Pharmaceuticals Ltd Satellite Overseas (Holdings) Ltd 10% Owner | 2014-03-21 17:43:06 | 0 9,500,000 | 9,500,000 | Form 4 |
| Modi Rajiv I. Director | 2015-06-18 16:43:10 | 0 2,500,000 | 2,500,000 | Form 4 |
| Singhvi Rahul President, CEO | 2011-03-14 13:02:11 | 1,210,001 0 | 1,210,001 | Form 4 |
| Jacobs John C President and CEO | 2024-03-26 18:11:33 | 750,000 0 | 750,000 | Form 4 |
| DRISCOLL FREDERICK W VP, CFO & Treasurer | 2013-03-06 19:11:13 | 730,000 0 | 730,000 | Form 4 |
| WRIGHT D CRAIG Chief Scientific Officer | 2004-03-15 16:34:47 | 428,524 0 | 428,524 | Form 4 |
| SIMS NELSON M Former President & CEO | 2005-08-16 15:50:08 | 275,000 0 | 275,000 | Form 4/A |
| MARSH JOHN O JR Director | 2014-03-07 18:49:42 | 225,000 0 | 225,000 | Form 4 |
| Thornton Mark Owens SVP & Chief Medical Officer | 2010-05-25 08:19:03 | 225,000 0 | 225,000 | Form 3 |
| Wilson Russell P SVP, Business Development | 2015-03-09 18:25:26 | 200,000 0 | 200,000 | Form 4 |
| Kelly James Patrick EVP, CFO & Treasurer | 2024-03-26 19:01:36 | 176,000 0 | 176,000 | Form 4 |
| WALKER RONLAD H Director | 2004-03-15 16:30:23 | 152,500 0 | 152,500 | Form 4 |
| Hahn Timothy Jon SVP, Manufacturing | 2015-03-09 18:26:49 | 150,000 0 | 150,000 | Form 4 |
| Trizzino John EVP, CCO and CBO | 2024-03-26 19:03:07 | 144,000 0 | 144,000 | Form 4 |
| Dubovsky Filip President, R&D | 2024-03-26 19:00:53 | 144,000 0 | 144,000 | Form 4 |
| O'Hara Elaine EVP, Chief Strategy Officer | 2024-03-26 19:02:19 | 120,000 0 | 120,000 | Form 4 |
| KELLY MITCHELL J Director | 2006-03-21 16:29:10 | 95,000 500 | 95,500 | Form 4/A |
| YOUNG JAMES F Director | 2023-06-13 16:49:15 | 82,970 1500 | 84,470 | Form 4 |
| BOUDREAUX GAIL Director | 2017-03-20 16:18:00 | 80,000 0 | 80,000 | Form 4 |
| Robinson Jim VP, Technical & Quality Ops. | 2009-03-09 16:05:30 | 75,000 0 | 75,000 | Form 4 |
| Johnston Thomas Scott Vice President, Strategy | 2010-03-17 14:31:28 | 60,000 0 | 60,000 | Form 4 |
| MOTT DAVID M Director | 2023-06-13 16:47:44 | 58,180 0 | 58,180 | Form 4 |
| DOUGLAS RICHARD Director | 2023-06-13 16:44:33 | 51,630 0 | 51,630 | Form 4 |
| Erck Stanley C President and CEO | 2022-12-16 17:00:48 | 43,459 0 | 43,459 | Form 4 |
| PHILLIPS BARCLAY A SVP, Chief Financial Officer | 2017-08-01 17:26:11 | 38,669 0 | 38,669 | Form 4 |
| Hall Patricia Chief Accounting Officer | 2006-11-01 18:21:00 | 38,264 0 | 38,264 | Form 4 |
| Glenn Gregory M President, R&D | 2023-03-14 17:16:58 | 30,935 0 | 30,935 | Form 4 |
| King Rachel K. Director | 2023-06-13 16:46:05 | 24,430 2200 | 26,630 | Form 4 |
| Stigliano Len F VP, CFO, Treasurer | 2008-08-04 13:58:50 | 25,831 0 | 25,831 | Form 4 |
| CHURCH JEFFREY WAYNE VP, CFO, Treasurer & Corp. Sec | 2007-03-09 17:25:00 | 25,000 0 | 25,000 | Form 4 |
| EVANS GARY C Director | 2021-06-22 17:12:19 | 19,549 0 | 19,549 | Form 4 |
| Heaton Penny VP & Chief Medical Officer | 2009-07-06 16:32:47 | 18,667 0 | 18,667 | Form 4 |
| Alton Gregg H Director | 2023-06-13 16:43:20 | 18,180 0 | 18,180 | Form 4 |
| MCGLYNN MARGARET G Director | 2023-06-13 16:47:02 | 18,180 0 | 18,180 | Form 4 |
| COVINO GREGORY F EVP, Chief Financial Officer | 2020-11-18 18:06:33 | 15,500 0 | 15,500 | Form 4 |
| ODONNELL DENIS M Director | 2007-03-09 15:47:21 | 15,000 0 | 15,000 | Form 4 |
| LAZARUS J MICHAEL MD Director | 2006-02-22 14:36:25 | 15,000 0 | 15,000 | Form 4 |
| TANANBAUM JAMES B Director | 2009-03-09 17:38:51 | 15,000 0 | 15,000 | Form 4 |
| Monath Thomas P Director | 2009-03-09 15:48:07 | 15,000 0 | 15,000 | Form 4 |
| Herrmann John A III EVP, Chief Legal Officer | 2023-12-18 17:09:21 | 13,233 0 | 13,233 | Form 4 |
| Casey Mark J EVP, CLO & Corporate Secretary | 2024-03-26 19:00:09 | 12,000 0 | 12,000 | Form 4 |
| Rodgers Richard J Director | 2023-10-31 16:43:35 | 11,400 0 | 11,400 | Form 4 |
| MCMANUS MICHAEL A JR Director | 2022-06-21 20:48:52 | 10,101 0 | 10,101 | Form 4 |
| GENGE DENNIS W VP, Treasurer,CFO | 2006-02-22 14:28:45 | 6400 0 | 6400 | Form 4 |
| Hage Raymond Joseph Sr. VP. Commercial Operations | 2009-07-06 16:37:26 | 5251 0 | 5251 | Form 4 |
| LAMBERT JOHN A Director | 2010-04-16 14:48:55 | 5000 0 | 5000 | Form 4 |
| Kopsidas Evdoxia E Sr.Dir.Fin.,Prin.Acctg.Officer | 2009-06-19 16:04:10 | 5000 0 | 5000 | Form 4 |
| LYNCH FORD R Sr. VP Marketing and Sales | 2004-07-27 15:40:50 | 4300 0 | 4300 | Form 4 |
| KING PHARMACEUTICALS INC 10% Owner | 2005-10-13 17:11:50 | 0 0 | 0 | Form 13D |
| BAYH SUSAN B Director | 2005-05-06 13:37:31 | 0 0 | 0 | Form 4 |
| SJ STRATEGIC INVESTMENTS LLC GREGORY JOHN M 10% Owner | 2005-11-04 12:05:08 | 0 0 | 0 | Form 13D |